HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,200 | +5.9% | 6,000 | 0.0% | 0.06% | +15.1% |
| Q2 2023 | $216,420 | -81.6% | 6,000 | -90.0% | 0.05% | -87.6% |
| Q1 2018 | $1,178,000 | -3.0% | 60,153 | 0.0% | 0.43% | +10.3% |
| Q4 2017 | $1,215,000 | +16.3% | 60,153 | 0.0% | 0.39% | +13.5% |
| Q3 2017 | $1,045,000 | +35.0% | 60,153 | -0.3% | 0.34% | +31.5% |
| Q2 2017 | $774,000 | -61.7% | 60,353 | -61.3% | 0.26% | -62.3% |
| Q1 2017 | $2,021,000 | – | 155,957 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |